torcetrapib has been researched along with dithionitrobenzoic acid in 1 studies
| Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (dithionitrobenzoic acid) | Trials (dithionitrobenzoic acid) | Recent Studies (post-2010) (dithionitrobenzoic acid) |
|---|---|---|---|---|---|
| 273 | 28 | 83 | 1,884 | 0 | 144 |
| Protein | Taxonomy | torcetrapib (IC50) | dithionitrobenzoic acid (IC50) |
|---|---|---|---|
| Thymidylate kinase | Homo sapiens (human) | 1.53 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gugliucci, A | 1 |
1 other study(ies) available for torcetrapib and dithionitrobenzoic acid
| Article | Year |
|---|---|
Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Topics: Adult; Apolipoproteins; Aryldialkylphosphatase; Carboxylic Ester Hydrolases; Dithionitrobenzoic Acid; Enzyme Activation; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Protein Transport; Quinolines; Time Factors; Young Adult | 2014 |